Prosecution Insights
Last updated: October 04, 2026

Lex Generalis, LLC

Technology area: Biotechnology & Pharmaceuticals

20 pending office actions • 7 clients • 20 examiners • 16 art units • 0 of 20 (0%) have an AI response strategy ready

Analysis

Lex Generalis, LLC manages a portfolio in Biotechnology & Pharmaceuticals with 191 career applications. The firm maintains a resolved allowance rate of 78.89 percent for applications that reach a final resolution. Achieving these results involves an average of 2.99 office actions per allowance. Currently, the firm has 16 pending office actions to address.

The 191 career applications and 78.89 percent allowance rate reflect the firm's practice in its primary technology area. The 2.99 average office actions per allowance provides a benchmark for expected examiner interaction during the patent acquisition process. These figures offer a data-grounded view of the firm's historical performance and current workload for practitioners evaluating the firm's Biotechnology & Pharmaceuticals experience.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Quality Metrics (n=191 apps, methodology: how we score firms)

78.9%
Allowance Rate
n=191
+0.49σ
Allowance Rate (norm)
n=191
3.0
OAs to Allowance
n=71
-0.35σ
OAs to Allow (norm)
n=71
1191 days
Time to Allowance
n=71
+8.5pp
Interview Lift
n=191
40.0%
RCE Rate
n=191
1.5%
Appeal Rate
n=191

Rejection Performance (% of received rejections ultimately overcome)

—
§101 Overcome
n=16 (min 20)
50.8%
§102 Overcome
n=59
50.0%
§103 Overcome
n=74
54.0%
§112 Overcome
n=76

Specialization & Scale

A61K, C12N, B01D
Top CPC Subclasses
17%
Top-3 CPC Share
n=191
1
Practitioners
n=191
191.0
Apps / Practitioner
n=191

Portfolio Summary

20
Total Pending OAs
12
Non-Final OAs
8
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
4
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (4)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

12
Hard (60%)
5
Medium (25%)
3
Easy (15%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other3 (15%)
§103 only4 (20%)
§102 only1 (5%)
§112 only3 (15%)
Multi-statute (no §101)9 (45%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

16
Life Sciences
80% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
1
Semiconductors
5% of docket
1
Mechanical / Eng
5% of docket
2
Business / Other
10% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

200 h
Manual time on pending OAs
40 h
Time saved (low, 20%)
70 h
Time saved (mid, 35%)
1.8 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
STOCKDALE, JESSICA NICOLE 1 50.0% +35.2%
PATEL, DEVANG R 1 65.6% +39.2%
DEVEAU ROSEN, JASON 1 80.1% +16.5%
JOHNSON, EMILY KATHARINE 1 87.5% +21.9%
GEBREMICHAEL, BRUK A 1 22.1% +23.4%
HUSON, MONICA ANNE 1 79.6% +13.5%
DECASTRO, ARIANA JOY LACAY 1 0.0% +0.0%
LEONARD, ARTHUR S 1 50.8% +50.2%
MARVICH, MARIA 1 54.9% +28.1%
LAN, YAN 1 63.1% +21.9%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18730449 NUDIX OVEREXPRESSING ENGINEERED PLANTS AND USES THEREOF JOHNSON, EMILY KATHARINE 8d

Hard Cases (13)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
17769992 FORMULATIONS FOR TREATMENT OF VIBRIO INFECTIONS PROSSER, ALISSA J 88d overdue
17556493 LIFECYCLE ASSESSMENT SYSTEMS AND METHODS FOR DETERMINING EMISSIONS FROM ANIMAL PRODUCTION BICKHAM, DAWN MARIE 51d overdue
18037098 VIBRIO TOXIN BINDING PROTEINS IN SHRIMP AND USES THEREOF STEELE, AMBER D 3d overdue
18289409 CONJUGATED LINOLEIC ACID SUPPLEMENTATION FOR DISEASE TREATMENT SCHMITT, MICHAEL J 29d
18750731 WEARABLE SPINAL TRAINING DEVICE GEBREMICHAEL, BRUK A 30d
18298082 SOYBEANS HAVING LOW TRYPSIN INHIBITOR EXPRESSION OR ACTIVITY SPEED, DEQUANTARIUS JAVON 41d
19305739 HETEROLOGOUS DDP1 EXPRESSING PLANTS AND USES THEREOF STOCKDALE, JESSICA NICOLE —
18847106 ENGINEERED PLANTS HAVING MODIFIED INOSITOL PYROPHOSPHATES DEVEAU ROSEN, JASON —

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18730449 NUDIX OVEREXPRESSING ENGINEERED PLANTS AND USES THEREOF JOHNSON, EMILY KATHARINE 8d
18750731 WEARABLE SPINAL TRAINING DEVICE GEBREMICHAEL, BRUK A 30d
19305739 HETEROLOGOUS DDP1 EXPRESSING PLANTS AND USES THEREOF STOCKDALE, JESSICA NICOLE —
19145847 SMALL-SCALE SOLID-STATE ADDITIVE MANUFACTURING TOOLS AND DESIGNS PATEL, DEVANG R —
18847106 ENGINEERED PLANTS HAVING MODIFIED INOSITOL PYROPHOSPHATES DEVEAU ROSEN, JASON —
18695210 CASCADE DEGRADATION AND UPCYCLING OF POLYSTYRENE WASTE TO HIGH VALUE CHEMICALS HUSON, MONICA ANNE —
18578856 ENGINEERED S. TYPHIMURIUM AND USES THEREOF LEONARD, ARTHUR S —
18574777 ENGINEERED NODAVIRAL CARGO DELIVERY SYSTEMS MARVICH, MARIA —

Client Portfolio (7 clients)

Top Art Units

Art UnitApps
16632
16622
17351
37151
16311
16341
17821
16291
16821
28531

Pending Office Actions

App #TitleClientExaminerArt UnitStatutesStatusDue inAIFiled
19305739 HETEROLOGOUS DDP1 EXPRESSING PLANTS AND USES THEREOF VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. STOCKDALE, JESSICA NICOLE 1663 §102§112 Non-Final OA — Pending Aug 20, 2025
19145847 SMALL-SCALE SOLID-STATE ADDITIVE MANUFACTURING TOOLS AND DESIGNS Virginia Tech Intellectual Properties PATEL, DEVANG R 1735 §103 Non-Final OA — Pending Jul 03, 2025
18847106 ENGINEERED PLANTS HAVING MODIFIED INOSITOL PYROPHOSPHATES VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. DEVEAU ROSEN, JASON 1662 §102§103§112 Non-Final OA — Pending Sep 13, 2024
18730449 NUDIX OVEREXPRESSING ENGINEERED PLANTS AND USES THEREOF VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. JOHNSON, EMILY KATHARINE 1662 §103 Final Rejection 8d Pending Jul 19, 2024
18750731 WEARABLE SPINAL TRAINING DEVICE Edward Via College Of Osteopathic Medicine GEBREMICHAEL, BRUK A 3715 §103 Non-Final OA 30d Pending Jun 21, 2024
18695210 CASCADE DEGRADATION AND UPCYCLING OF POLYSTYRENE WASTE TO HIGH VALUE CHEMICALS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. HUSON, MONICA ANNE §112 Non-Final OA — Pending Mar 25, 2024
18591957 DEVICE AND METHOD FOR ARTIFICIAL INSEMINATION Innomed One, LLC DECASTRO, ARIANA JOY LACAY §103§112 Non-Final OA — Pending Feb 29, 2024
18578856 ENGINEERED S. TYPHIMURIUM AND USES THEREOF VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. LEONARD, ARTHUR S 1631 §102§103§112 Non-Final OA — Pending Jan 12, 2024
18574777 ENGINEERED NODAVIRAL CARGO DELIVERY SYSTEMS Arizona Board of Regents MARVICH, MARIA 1634 §112 Non-Final OA — Pending Dec 28, 2023
18559525 SOLID-INFUSED SURFACES, ARTICLES INCORPORATING SOLID-INFUSED SURFACES, METHODS OF MAKING, AND METHODS OF USE THEREOF VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. LAN, YAN 1782 §102§103§112 Non-Final OA — Pending Nov 07, 2023
18289409 CONJUGATED LINOLEIC ACID SUPPLEMENTATION FOR DISEASE TREATMENT VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. SCHMITT, MICHAEL J 1629 §102§103§112 Final Rejection 29d Pending Nov 03, 2023
18285876 ISOTHERMAL AMPLIFICATION-BASED DETECTION OF SHRIMP PATHOGENS Arizona Board of Regents GOLDBERG, JEANINE ANNE 1682 §103 Final Rejection 26d Pending Oct 06, 2023
18282193 MULTI-INSTRUMENT DEVICE BASED ON PARTIAL RECONFIGURATION FPGA Liquid Instruments Pty. Ltd. DO, AN H 2853 §102 Non-Final OA — Pending Sep 14, 2023
18281503 METHODS AND APPARATUS FOR EVAPORATION BASED LIQUID TRANSPORT VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. GORDON, BRIAN R 1798 §102§103§112 Final Rejection — Pending Sep 11, 2023
18037098 VIBRIO TOXIN BINDING PROTEINS IN SHRIMP AND USES THEREOF Arizona Board of Regents STEELE, AMBER D 1658 §101§103§112 Final Rejection 3d overdue Pending May 16, 2023
18298082 SOYBEANS HAVING LOW TRYPSIN INHIBITOR EXPRESSION OR ACTIVITY VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. SPEED, DEQUANTARIUS JAVON 1663 §102§103§112 Non-Final OA 41d Pending Apr 10, 2023
18030250 COMPOSITIONS AND METHODS OF TREATING A PI3K MEDIATED DISEASE VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. D' AMBROSIO, THEA 1654 §112 Final Rejection 31d overdue Pending Apr 04, 2023
17769992 FORMULATIONS FOR TREATMENT OF VIBRIO INFECTIONS Arizona Board of Regents PROSSER, ALISSA J 1619 §102§103§112 Final Rejection 88d overdue Pending Apr 18, 2022
17556493 LIFECYCLE ASSESSMENT SYSTEMS AND METHODS FOR DETERMINING EMISSIONS FROM ANIMAL PRODUCTION Low Carbon Technologies, LLC BICKHAM, DAWN MARIE 1685 §101§102§103Other Final Rejection 51d overdue Pending Dec 20, 2021
17419274 CHEMICALLY PROGRAMMED NEUTROPHILS AND USES THEREOF VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. BARRON, SEAN C 1653 §101§102§103§112 Non-Final OA — Pending Jun 28, 2021

Managing Lex Generalis, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month